-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FVEoikYE+790ANxk3PUr+X0voE1bLiFZwSnBVhI9rKrq8Cu0Rk1+wibleMkrYhRB
 43W9HeQDIUcMxW/Psvi9Fg==

<SEC-DOCUMENT>0001204459-08-001069.txt : 20080516
<SEC-HEADER>0001204459-08-001069.hdr.sgml : 20080516
<ACCEPTANCE-DATETIME>20080516163134
ACCESSION NUMBER:		0001204459-08-001069
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080509
FILED AS OF DATE:		20080516
DATE AS OF CHANGE:		20080516

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China Biologic Products, Inc.
		CENTRAL INDEX KEY:			0001369868
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			F4
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		NO.14 EAST HUSHAN ROAD
		CITY:			TAI'AN CITY, SHANDONG
		STATE:			F4
		ZIP:			271000
		BUSINESS PHONE:		86-538-620-3897

	MAIL ADDRESS:	
		STREET 1:		NO.14 EAST HUSHAN ROAD
		CITY:			TAI'AN CITY, SHANDONG
		STATE:			F4
		ZIP:			271000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRC Holdings, Inc.
		DATE OF NAME CHANGE:	20060721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Li Lin Ling
		CENTRAL INDEX KEY:			0001411870

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52807
		FILM NUMBER:		08842712

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		865386203897

	MAIL ADDRESS:	
		STREET 1:		14 EAST HUSHAN ROAD
		STREET 2:		TAIAN CITY
		CITY:			SHANDONG
		STATE:			F4
		ZIP:			271000
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-05-09</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001369868</issuerCik>
        <issuerName>China Biologic Products, Inc.</issuerName>
        <issuerTradingSymbol>CBPO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001411870</rptOwnerCik>
            <rptOwnerName>Li Lin Ling</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>14 EAST HUSHAN ROAD</rptOwnerStreet1>
            <rptOwnerStreet2>TAIAN CITY</rptOwnerStreet2>
            <rptOwnerCity>SHANDONG</rptOwnerCity>
            <rptOwnerState>F4</rptOwnerState>
            <rptOwnerZipCode>271000</rptOwnerZipCode>
            <rptOwnerStateDescription>CHINA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $.001 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6862624</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Non-Qualified Stock Option</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>4</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-05-09</value>
            </transactionDate>
            <deemedExecutionDate>
                <value>2008-05-09</value>
            </deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>50000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2008-05-09</value>
            </exerciseDate>
            <expirationDate>
                <value>2018-05-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>50000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6912624</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On May 9, 2008 the Board of Directors of the Issuer granted to the Reporting Person ten year non-qualified stock options to purchase 50,000 shares of the Issuer's common stock.  The options were granted under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated May 9, 2008, entered into between the Issuer and the Reporting Person and the options vested immediately on May 9, 2008.  As a result, the Reporting Person is now the beneficial owner of 6,912,624 shares of Common Stock.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/Lin Ling Li</signatureName>
        <signatureDate>2008-05-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----